Sep 24, 2021
On September 13, 2021, aTyr Pharma announced positive results from their Phase1b/2a clinical trial for ATYR1923 in pulmonary sarcoidosis. FSR is proud to have supported this clinical trial. The trial demonstrated that ATYR1923 was safe and well-tolerated, 33%...Topics: Living with Sarcoidosis/ News/ Other/ Research
Aug 30, 2021
Updated January, 2022 What to know about Omicron, the vaccines, the boosters, and staying safe The Omicron variant of the COVID-19 virus is now the dominant variant in the United States and since December cases have been skyrocketing. Vaccines and boosters ...Topics: COVID-19/ News
Aug 23, 2021
Sarcoidosis does not automatically indicate an immunocompromised diagnosis. FSR cannot determine or provide recommendations for your individual immunocompromised status. Please consult your physician for personalized medical advice. On Friday, August 13, 2021, the...Topics: COVID-19/ Living with Sarcoidosis/ News
Jul 19, 2021
We are thrilled to announce the formation of our new FSR Patient Speakers’ Bureau! This bureau consists of 14 experienced and trained sarcoidosis patient advocates who will share their personal stories to advocate for FSR and raise awareness for...Topics: Advocacy/ Living with Sarcoidosis/ News/ Other/ Patient Voices
Jun 4, 2021
The Foundation for Sarcoidosis Research (FSR) is pleased to announce the Foundation for Sarcoidosis Research Fellowship Grant for 2021-2023 is being awarded to Dr. Paula Berreras from Johns Hopkins University Hospital for her project, “Discovering pathogens in...Topics: News/ Research
May 25, 2021
The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, is pleased to announce the appointment of three new members to its Board of...Topics: News
May 20, 2021
Foundation for Sarcoidosis Research is seeking applicants for our first Women of Color Committee. African Americans in the U.S. have been the group most affected by sarcoidosis with an estimated lifetime risk as high as 2% among the population. Additionally, African...Topics: Living with Sarcoidosis/ News/ Patient Voices
May 5, 2021
Authors: Arindam Singha, MD1; Tricha Shivas, MBe2 ; Elliot D. Crouser, MD1 Since it was declared a global pandemic in March of 2020, the coronavirus disease 2019 (COVID-19) has affected over 100 million lives globally. It has been demonstrated that patients...Topics: COVID-19/ Living with Sarcoidosis/ News/ Other/ Research
Feb 24, 2021
CHICAGO, Feb. 24, 2021 /PRNewswire/ — The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, is pleased to announce the appointment...Topics: News
Jan 11, 2021
FSR is nothing without the efforts of our volunteers. While FSR has kept our Advocate applications open year-round and will continue to do so throughout 2021, if you’re looking to step up your involvement, or step into a new role, now is the time! FSR always welcomes...Topics: News/ Take Action
